FDA Approves Aemcolo (rifamycin) to Treat Travelers ’ Diarrhea

November 16, 2018 -- The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers’ diarrhea caused by noninvasive strains of Escherichia coli (E....
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news